SWOV Catalogus


Benzodiazepine, alcohol, and other drug use among injured motor vehicle crash drivers.
C 18033 (In: C 17992 S) /83 / ITRD E203825
Maio, R.F. Guthrie, S.K. Hill, E.M. Gregor, M.A. Waller, P.F. & Blow, F.C.
In: Proceedings of the 44th Annual Conference of the Association for the Advancement of Automotive Medicine AAAM, Chicago, Illinois, October 2-4, 2000, p. 505-507

Samenvatting The purpose of the study presented in this scientific poster was threefold: (1) to determine frequency of +benzodiazepine (BZD) tests among injured motor vehicle crash (MVC) drivers; (2) to describe the injury and crash characteristics of these individuals; and (3) to determine the relationship of a +BZD test to crash characteristics, crash culpability and injury severity. This was a hybrid study consisting of a retrospective analysis using data from a previously conducted study on alcohol, cannabinoids, opiates and MVC injury. 708 driver blood samples were available for analysis for BZD. The study suggests that a positive laboratory test for BZD among injured MVC drivers is relatively infrequent. Injured +BZD drivers are more likely to be culpable and to not be wearing a seat belt compared to their -BZD counterparts, however, +BZD patients have lower anatomic injury severity and are less likely to be admitted. A substantial portion of these +BZD drivers may be taking BZDs without appropriate indications. Concomitant alcohol and/or illicit drug use occurs frequently among +BZD patients. Multicenter prospective studies need to be conducted to adequately evaluate the effect of BZD use on MVC injury.
Suggestie? Neem contact op met de SWOV bibliotheek voor uw opmerkingen
Copyright © SWOV | Juridisch voorbehoud | Contact